Erin Meredith

Erin Meredith is the Director of Clinical Operations at Nurix Therapeutics, a biopharmaceutical company focused on developing targeted protein modulation drugs for cancer and other challenging diseases.12 She has been with Nurix Therapeutics since October 2019, progressing through various roles within the company.1

Career Progression at Nurix Therapeutics

• Director Clinical Operations: March 2023 - Present
• Associate Director Clinical Operations: July 2021 - March 2023
• Clinical Program Manager: October 2019 - July 2021

Previous Experience

Before joining Nurix, Erin held several positions in the pharmaceutical and healthcare industry:

• Study Project Manager at AbbVie Stemcentrx (July 2018 - October 2019)
• Study Management Associate III at Stemcentrx, Inc. (July 2016 - July 2018)
• Clinical Project Assistant at Gilead Sciences (January 2015 - July 2016)
• Clinical Research Coordinator at Stanford University School of Medicine (February 2013 - January 2015)

Education

Erin's educational background includes:

• Post Baccalaureate Pre-Medical Program at Washington University in St. Louis (2010 - 2012)
• Undergraduate degree from Stanford University (2005 - 2009)

Unique Experience

Interestingly, Erin also has experience as a Professional Volleyball Player for Sm'Aesch Pfeffingen from August 2009 to June 2010.1

In her current role at Nurix Therapeutics, Erin is part of the Clinical Operations team responsible for planning, executing, and overseeing clinical trials that evaluate the efficacy and safety of novel immuno-oncology agents.2 Her work contributes to advancing innovative cancer therapies from concept to clinical application.